Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-02-23 | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma
(CEO & President) |
F | Common Stock | D | 9386 | $431.79 - $431.79 | $4,052,780 |
| 2024-02-26 | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A
(EVP, COO) |
S | Common Stock | D | 5034 | $425.70 - $425.70 | $2,142,973 |
| 2024-02-23 | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A
(EVP, COO) |
F | Common Stock | D | 4714 | $431.79 - $431.79 | $2,035,458 |
| 2024-02-21 | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward M...
(EVP, Chief Technical Ops. Off.) |
S | Common Stock | D | 1201 | $421.77 - $421.77 | $506,545 |
| 2024-02-20 | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania
(EVP, Chief Reg. & Quality Off.) |
S | Common Stock | D | 480 | $420.79 - $420.79 | $201,979 |
| 2024-02-16 | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania
(EVP, Chief Reg. & Quality Off.) |
F | Common Stock | D | 7872 | $420.58 - $424.01 | $3,326,236 |
| 2024-02-16 | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen
(EVP and CMO) |
F | Common Stock | D | 6562 | $420.58 - $424.01 | $2,772,707 |
| 2024-02-14 | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M
(Executive Chairman) |
S | Common Stock | D | 9011 | $419.04 - $419.16 | $3,776,527 |
| 2024-02-09 | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR
(EVP & Chief Financial Officer) |
F | Common Stock | D | 2607 | $422.74 - $422.74 | $1,102,083 |
| 2024-02-12 | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen
(SVP & Chief Accounting Officer) |
S | Common Stock | D | 1374 | $420.24 - $420.24 | $577,409 |
| 2024-02-09 | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen
(SVP & Chief Accounting Officer) |
F | Common Stock | D | 591 | $422.74 - $422.74 | $249,839 |
| 2024-02-12 | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID
(EVP, Global Research and CSO) |
S | Common Stock | D | 3145 | $420.24 - $420.24 | $1,321,654 |
| 2024-02-09 | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID
(EVP, Global Research and CSO) |
F | Common Stock | D | 2099 | $422.74 - $422.74 | $887,331 |
| 2024-02-08 | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M
(Executive Chairman) |
F | Common Stock | D | 10746 | $421.73 - $422.74 | $4,540,038 |
| 2024-02-06 | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR
(EVP & Chief Financial Officer) |
A | Common Stock | A | 22368 | $0.00 - $0.00 | $0 |
| 2024-02-06 | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania
(EVP, Chief Reg. & Quality Off.) |
A | Common Stock | A | 21956 | $0.00 - $0.00 | $0 |
| 2024-02-06 | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit
(EVP Chief Patient & Ext Af Off) |
A | Common Stock | A | 20794 | $0.00 - $0.00 | $0 |
| 2024-02-06 | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma
(CEO & President) |
A | Common Stock | A | 61815 | $0.00 - $0.00 | $0 |
| 2024-02-06 | VERTEX PHARMACEUTICALS INC / MA | Biller Jonathan
(EVP and Chief Legal Officer) |
A | Common Stock | A | 11037 | $0.00 - $0.00 | $0 |
| 2024-02-06 | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward M...
(EVP, Chief Technical Ops. Off.) |
A | Common Stock | A | 11003 | $0.00 - $0.00 | $0 |
| 2024-01-08 | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M
(Executive Chairman) |
S | Common Stock | D | 6648 | $419.07 - $419.07 | $2,785,977 |
| 2024-01-02 | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR
(EVP & Chief Financial Officer) |
S | Common Stock | D | 3000 | $405.00 - $405.00 | $1,215,000 |
| 2023-12-15 | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma
(CEO & President) |
S | Common Stock | D | 17135 | $407.00 - $407.00 | $6,973,945 |
| 2023-12-15 | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma
(CEO & President) |
M | Common Stock | A | 17135 | $155.57 - $187.53 | $3,115,592 |
| 2023-12-13 | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M
(Executive Chairman) |
S | Common Stock | D | 13354 | $399.41 - $400.19 | $5,333,799 |
| 2023-12-13 | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A
(EVP, COO) |
M | Common Stock | A | 8603 | $187.53 - $187.53 | $1,613,320 |
| 2023-12-05 | VERTEX PHARMACEUTICALS INC / MA | Thornberry Nancy
(Director) |
A | Common Stock | A | 1136 | $0.00 - $0.00 | $0 |
| 2023-11-20 | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR
(EVP & Chief Financial Officer) |
S | Common Stock | D | 3000 | $349.88 - $349.88 | $1,049,640 |
| 2023-11-15 | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit
(EVP Chief Patient & Ext Af Off) |
S | Common Stock | D | 35 | $369.92 - $369.92 | $12,947 |
| 2023-11-14 | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen
(EVP and CMO) |
S | Common Stock | D | 5650 | $380.82 - $380.82 | $2,151,633 |
| 2023-11-13 | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma
(CEO & President) |
S | Common Stock | D | 5097 | $377.00 - $377.00 | $1,921,569 |
| 2023-10-31 | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen
(EVP and CMO) |
S | Common Stock | D | 5651 | $355.92 - $355.92 | $2,011,303 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |